Asthma
COPD
Pulmonary
Pulmonary: Page 2
ERS publishes updated PAH guidelines
The revised recommendations add sotatercept and provide an evidence-based framework for managing patients with pulmonary arterial hypertension.
October 1, 2026
Protein-based MRI agent aids early lung cancer diagnosis
The targeted, noninvasive technology detects abnormal collagen development in lung tumors and metastatic lesions.
September 25, 2026
MRI reduces cognitive failure, adverse events in SCLC
Analysis supports MRI surveillance alone, rather than preventive brain radiation, as the standard of care approach for patients with small-cell lung cancer.
September 24, 2026
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
Common cold: There may be a vaccine for that
Early clinical trial results demonstrate safety and efficacy in preventing rhinovirus-related COPD and asthma exacerbations.
September 18, 2026
Inpatient PAH therapy transition deemed safe
Research supports concurrent switch from infusion treatment to oral medication over a closely monitored, continuous timeframe averaging 36 hours.
September 17, 2026
Foretelling the future of lung cancer recurrence
Researchers have discovered multiple noninvasive ways to predict risk and improve outcomes.
September 11, 2026
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
Seniors with lung disease benefit from 4x stronger flu vaccine
International studies confirmed the high-dose flu vaccine reduced hospitalizations in the high-risk population by almost 9%.
September 9, 2026
Can experimental drug prevent lung cancer?
MIT researchers suggest blocking caspase-1 could have a big impact on tumor development in high-risk patients.
September 3, 2026
Study reveals novel fibrotic cell type
Scientists have attributed the pericyte, Peri2, to detrimental lung scarring associated with pulmonary fibrosis.
September 3, 2026
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
In-depth study advances understanding of HFpEF
Researchers examine underlying mechanisms and severity of the common condition combined with pulmonary hypertension.
August 27, 2026
Combined metal exposure can cause chemotherapy resistance
Toxic damage to lung cancer tumors can be reversed with combination therapy approach.
August 26, 2026
Potential GLP-1 benefits for long COVID, diabetes
Breakthrough research reveals the drug’s possible defense against pulmonary fibrosis.
August 21, 2026
Previous Page
Page 2 of 30
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
Long-term impact of pediatric TB patients
COPD treatment falls short in phase 2 proof-of-concept trial
Merck begins phase 3 study for ensifentrine COPD treatment